S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond

Cardiovascular Psychiatry and Neurology

Volumn , Issue , 2010, Pages

  Donato, Rosario ^a   Sorci, Guglielmo ^a   Bianchi, Roberta ^a   Riuzzi, Francesca ^a   Tubaro, Claudia ^a   Arcuri, Cataldo ^a   Giambanco, Ileana ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; NEUROTOXIN; PROTEIN S100B;

APOPTOSIS; ASTROCYTE; BRAIN DISEASE; CALCIUM HOMEOSTASIS; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CYTOSKELETON; ENERGY METABOLISM; HEART DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; MICROGLIA; NEGATIVE FEEDBACK; NERVE CELL; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

EID: 77956865329     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2010/656481     Document Type: Review

References (142)

1. Donato R., S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles International Journal of Biochemistry and Cell Biology 2001 33 7 637 668
2. Marenholz I., Heizmann C. W., Fritz G., S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature) Biochemical and Biophysical Research Communications 2004 322 4 1111 1122
3. Heizmann C. W., Fritz G., Bradshaw R. A., Dennis E. A., The family of S100 cell signaling proteins Handbook of Cell Signaling 2009 2nd Oxford, UK Academic Press 983 994
4. Donato R., Perspectives in S-100 protein biology Cell Calcium 1991 12 10 713 726
5. Donato R., Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type Biochimica et Biophysica Acta 1999 1450 3 191 231
6. Heizmann C. W., Fritz G., Schfer B. W., S100 proteins: structure, functions and pathology Front Biosci 2002 7 1356 1368
7. Santamaria-Kisiel L., Rintala-Dempsey A. C., Shaw G. S., Calcium-dependent and -independent interactions of the S100 protein family Biochemical Journal 2006 396 2 201 214
8. Donato R., RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins Current Molecular Medicine 2007 7 8 711 724
9. Leclerc E., Fritz G., Vetter S. W., Heizmann C. W., Binding of S100 proteins to RAGE: an update Biochimica et Biophysica Acta 2009 1793 6 993 1007
10. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I., S100B's double life: intracellular regulator and extracellular signal Biochimica et Biophysica Acta 2009 1793 6 1008 1022
11. Tsoporis J. N., Overgaard C. B., Izhar S., Parker T. G., S100B modulates the hemodynamic response to norepinephrine stimulation American Journal of Hypertension 2009 22 10 1048 1053
12. Tubaro C., Arcuri C., Giambanco I., Donato R., S100B protein in myoblasts modulates myogenic differentiation via NF- B-dependent inhibition of MyoD expression Journal of Cellular Physiology 2010 223 1 270 282
13. Parker T. G., Marks A., Tsoporis J. N., Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy Canadian Journal of Applied Physiology 1998 23 4 377 389
14. Tsoporis J. N., Marks A., Van Eldik L. J., O'Hanlon D., Parker T. G., Regulation of the S100B gene by 1-adrenergic stimulation in cardiac myocytes American Journal of Physiology 2003 284 1 H193 H203
15. Tsoporis J. N., Marks A., Haddad A., Dawood F., Liu P. P., Parker T. G., S100B expression modulates left ventricular remodeling after myocardial infarction in mice Circulation 2005 111 5 598 606
16. Suzuki F., Kato K., Nakajima T., Hormonal regulation of adipose S-100 protein release Journal of Neurochemistry 1984 43 5 1336 1341
17. Sen J., Belli A., S100B in neuropathologic states: the CRP of the brain? Journal of Neuroscience Research 2007 85 7 1373 1380
18. Lin J., Blake M., Tang C., Zimmer D., Rustandi R. R., Weber D. J., Carrier F., Inhibition of p53 transcriptional activity by the S100B calcium-binding protein The Journal of Biological Chemistry 2001 276 37 35037 35041
19. Markowitz J., Chen I., Gitti R., Baldisseri D. M., Pan Y., Udan R., Carrier F., MacKerell A. D. Jr., Weber D. J., Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction Journal of Medicinal Chemistry 2004 47 21 5085 5093
20. Smith J., Stewart B. J., Glaysher S., Peregrin K., Knight L. A., Weber D. J., Cree I. A., The effect of pentamidine on melanoma ex vivo Anti-Cancer Drugs 2010 21 2 181 185
21. Arcuri C., Bianchi R., Brozzi F., Donato R., S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation The Journal of Biological Chemistry 2005 280 6 4402 4414
22. Brozzi F., Arcuri C., Giambanco I., Donato R., S100B protein regulates astrocyte shape and migration via interaction with Src Kinase: implications for astrocyte development, activation, and tumor growth The Journal of Biological Chemistry 2009 284 13 8797 8811
23. Saito T., Ikeda T., Nakamura K., Chung U.-I., Kawaguchi H., S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes EMBO Reports 2007 8 5 504 509
24. Raponi E., Agenes F., Delphin C., Assard N., Baudier J., Legraverend C., Deloulme J.-C., S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage Glia 2007 55 2 165 177
25. Rietze R. L., Reynolds B. A., Neural stem cell isolation and characterization Methods in Enzymology 2006 419 3 23
26. Whitaker-Azmitia P. M., Wingate M., Borella A., Gerlai R., Roder J., Azmitia E. C., Transgenic mice overexpressing the neurotrophic factor S-100 show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome Brain Research 1997 776 1-2 51 60
27. Esposito G., Imitola J., Lu J., De Filippis D., Scuderi C., Ganesh V. S., Folkerth R., Hecht J., Shin S., Iuvone T., Chesnut J., Steardo L., Sheen V., Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury Human Molecular Genetics 2008 17 3 440 457
28. Sofroniew M. V., Molecular dissection of reactive astrogliosis and Glial scar formation Trends in Neurosciences 2009 32 12 638 647
29. Rommel C., Camps M., Ji H., PI3K and PI3K : partners in crime in inflammation in rheumatoid arthritis and beyond? Nature Reviews Immunology 2007 7 3 191 201
30. Fruman D. A., Bismuth G., Fine tuning the immune response with PI3K Immunological Reviews 2009 228 1 253 272
31. Farina C., Aloisi F., Meinl E., Astrocytes are active players in cerebral innate immunity Trends in Immunology 2007 28 3 138 145
32. Herrera F., Chen Q., Fischer W. H., Maher P., Schubert D. R., Synaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down's syndrome Cell Death and Differentiation 2009 16 6 910 920
33. Wu C.-Y., Hsieh H.-L., Sun C.-C., Tseng C.-P., Yang C.-M., IL-1 induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes Journal of Neurochemistry 2008 105 4 1499 1512
34. Ke Y., Jiang G., Sun D., Kaplan H. J., Shao H., Retinal astrocytes respond to IL-17 differently than retinal pigment epithelial cells Journal of Leukocyte Biology 2009 86 6 1377 1384
35. Wang H.-H., Hsieh H.-L., Wu C.-Y., Sun C.-C., Yang C.-M., Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes Glia 2009 57 1 24 38
36. Wu J., Wrathall J. R., Schachner M., Phosphatidylinositol 3-Kinase/protein Kinase Cdelta activation induces close homolog of adhesion molecule L1 (CHL1) expression in cultured astrocytes Glia 2010 58 315 238
37. Kato H., Kurosaki R., Oki C., Araki T., Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice Brain Research 2004 1030 1 66 73
38. Asano T., Mori T., Shimoda T., Shinagawa R., Satoh S., Yada N., Katsumata S., Matsuda S., Kagamiishi Y., Tateishi N., Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B Current Drug Targets 2005 4 2 127 142
39. Mori T., Tan J., Arendash G. W., Koyama N., Nojima Y., Town T., Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia Stroke 2008 39 7 2114 2121
40. Wainwright M. S., Craft J. M., Griffin W. S. T., Marks A., Pineda J., Padgett K. R., Van Eldik L. J., Increased susceptibility of S100B transgenic mice to peinatal hypoxia-ischemia Annals of Neurology 2004 56 1 61 67
41. Mori T., Koyama N., Arendash G. W., Horikoshi-Sakuraba Y., Tan J., Town T., Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease Glia 2010 58 3 300 314
42. Van Eldik L. J., Wainwright M. S., The Janus face of Glial-derived S100B: beneficial and detrimental functions in the brain Restorative Neurology and Neuroscience 2003 21 3-4 97 108
43. Xiong Z.-G., O'Hanlon D., Becker L. E., Roder J., MacDonald J. F., Marks A., Enhanced calcium transients in Glial cells in neonatal cerebellar cultures derived from S100B null mice Experimental Cell Research 2000 257 2 281 289
44. Haase H., Alvarez J., Petzhold D., Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation The FASEB Journal 1999 13 2161 2172
45. Lee I. H., You J. O., Ha K. S., Bae D. S., Suh P.-G., Rhee S. G., Bae Y. S., AHNAK-mediated activation of phospholipase C- 1 through protein Kinase C The Journal of Biological Chemistry 2004 279 25 26645 26653
46. Gentil B. J., Delphin C., Benaud C., Baudier J., Expression of the giant protein AHNAK (desmoyokin) in muscle and lining epithelial cells Journal of Histochemistry and Cytochemistry 2003 51 3 339 348
47. Gentil B. J., Delphin C., Mbele G. O., Deloulme J. C., Ferro M., Garin J., Baudier J., The giant protein AHNAK is a specific target for the calcium-and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B The Journal of Biological Chemistry 2001 276 26 23253 23261
48. Michetti F., Massaro A., Murazio M., The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients Neuroscience Letters 1979 11 2 171 175
49. Shashoua V. E., Hesse G. W., Moore B. W., Proteins of the brain extracellular fluid: evidence for release of S-100 protein Journal of Neurochemistry 1984 42 6 1536 1541
50. Van Eldik L. J., Zimmer D. B., Secretion of S-100 from rat C6 glioma cells Brain Research 1987 436 2 367 370
51. Nardin P., Tortorelli L., Quincozes-Santos A., de Almeida L. M. V., Leite M. C., Thomazi A. P., Gottfried C., Wofchuk S. T., Donato R., Gonalves C.-A., S100B secretion in acute brain slices: modulation by extracellular levels of Ca2+ and K+ Neurochemical Research 2009 34 9 1603 1611
52. de Souza D. F., Leite M. C., Quincozes-Santos A., Nardin P., Tortorelli L. S., Rigo M. M., Gottfried C., Leal R. B., Gonalves C.-A., S100B secretion is stimulated by IL-1 in Glial cultures and hippocampal slices of rats: likely involvement of MAPK pathway Journal of Neuroimmunology 2009 206 1-2 52 57
53. Leite M. C., Galland F., de Souza D. F., Guerra M. C., Bobermin L., Biasibetti R., Gottfried C., Gonalves C.-A., Gap junction inhibitors modulate S100B secretion in astrocyte cultures and acute hippocampal slices Journal of Neuroscience Research 2009 87 11 2439 2446
54. Ostendorp T., Leclerc E., Galichet A., Koch M., Demling N., Weigle B., Heizmann C. W., Kroneck P. M. H., Fritz G., Structural and functional insights into RAGE activation by multimeric S100B The EMBO Journal 2007 26 16 3868 3878
55. Ma W., Lee S. E., Guo J., Qu W., Hudson B. I., Schmidt A. M., Barile G. R., RAGE ligand upregulation of VEGF secretion in ARPE-19 cells Investigative Ophthalmology and Visual Science 2007 48 3 1355 1361
56. Kligman D., Marshak D. R., Purification and characterization of a neurite extension factor from bovine brain Proceedings of the National Academy of Sciences of the United States of America 1985 82 20 7136 7139
57. Marshak D. R., Pesce S. A., Stanley L. C., Griffin W. S. T., Increased S100 neurotrophic activity in Alzheimer's disease temporal lobe Neurobiology of Aging 1992 13 1 1 7
58. Fan G., Mariggi M. A., Angelella P., Nicoletti I., Antonica A., Fulle S., Calissano P., The S-100 protein causes an increase of intracellular calcium and death of PC12 cells Neuroscience 1993 53 4 919 925
59. Hu J., Ferreira A., Van Eldik L. J., S100 induces neuronal cell death through nitric oxide release from astrocytes Journal of Neurochemistry 1997 69 6 2294 2301
60. Petrova T. V., Hu J., Van Eldik L. J., Modulation of Glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microGlial cultures Brain Research 2000 853 1 74 80
61. Adami C., Sorci G., Blasi E., Agneletti A. L., Bistoni F., Donato R., S100B expression in and effects on microGlia Glia 2001 33 2 131 142
62. Hu J., Castets F., Guevara J. L., Van Eldiki L. J., S100 stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes The Journal of Biological Chemistry 1996 271 5 2543 2547
63. Lam A. G. M., Koppal T., Akama K. T., Guo L., Craft J. M., Samy B., Schavocky J. P., Martin Watterson D., Van Eldik L. J., Mechanism of Glial activation by S100B: involvement of the transcription factor NF B Neurobiology of Aging 2001 22 5 765 772
64. Bianchi R., Adami C., Giambanco I., Donato R., S100B binding to RAGE in microGlia stimulates COX-2 expression Journal of Leukocyte Biology 2007 81 1 108 118
65. Ponath G., Schettler C., Kaestner F., Voigt B., Wentker D., Arolt V., Rothermundt M., Autocrine S100B effects on astrocytes are mediated via RAGE Journal of Neuroimmunology 2007 184 1-2 214 222
66. Bianchi R., Giambanco I., Donato R., S100B/RAGE-dependent activation of microGlia via NF- B and AP-1. Co-regulation of COX-2 expression by S100B, IL-1 and TNF- Neurobiology of Aging 2008 31 47 665 677
67. Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 1999 97 7 889 901
68. Huttunen H. J., Kuja-Panula J., Sorci G., Agneletti A. L., Donato R., Rauvala H., Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation The Journal of Biological Chemistry 2000 275 51 40096 40105
69. Sorci G., Riuzzi F., Agneletti A. L., Marchetti C., Donato R., S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner Molecular and Cellular Biology 2003 23 14 4870 4881
70. Sorci G., Riuzzi F., Agneletti A. L., Marchetti C., Donato R., S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner Journal of Cellular Physiology 2004 199 2 274 283
71. Riuzzi F., Sorci G., Donato R., S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK Journal of Cellular Physiology 2006 207 2 461 470
72. Adami C., Bianchi R., Pula G., Donato R., S100B-stimulated NO production by BV-2 microGlia is independent of RAGE transducing activity but dependent on RAGE extracellular domain Biochimica et Biophysica Acta 2004 1742 13 169 177
73. Esposito G., De Filippis D., Cirillo C., Sarnelli G., Cuomo R., Iuvone T., The astroGlial-derived S100 protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP Kinase activation Life Sciences 2006 78 23 2707 2715
74. Omori K., Ohira T., Uchida Y., Ayilavarapu S., Batista E. L. Jr., Yagi M., Iwata T., Liu H., Hasturk H., Kantarci A., Van Dyke T. E., Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase Journal of Leukocyte Biology 2008 84 1 292 301
75. Businaro R., Leone S., Fabrizi C., Sorci G., Donato R., Lauro G. M., Fumagalli L., S100B protects LAN-5 neuroblastoma cells against A amyloid-induced neurotoxicity via RAGE engagement at low doses but increases A amyloid neurotoxicity at high doses Journal of Neuroscience Research 2006 83 5 897 906
76. Lue L.-F., Walker D. G., Brachova L., Beach T. G., Rogers J., Schmidt A. M., Stern D. M., Yan S. D., Involvement of microGlial receptor for advanced glycation endproducts (RAGE)in Alzheimer's disease: identification of a cellular activation mechanism Experimental Neurology 2001 171 1 29 45
77. Schmidt A. M., Yan S. D., Yan S. F., Stern D. M., The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses The Journal of Clinical Investigation 2001 108 7 949 955
78. Bierhaus A., Humpert P. M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D. M., Nawroth P. P., Understanding RAGE, the receptor for advanced glycation end products Journal of Molecular Medicine 2005 83 11 876 886
79. Xie J., Reverdatto S., Frolov A., Hoffmann R., Burz D. S., Shekhtman A., Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE) The Journal of Biological Chemistry 2008 283 40 27255 27269
80. Glezer I., Simard A. R., Rivest S., Neuroprotective role of the innate immune system by microGlia Neuroscience 2007 147 4 867 883
81. Hanisch U.-K., Kettenmann H., MicroGlia: active sensor and versatile effector cells in the normal and pathologic brain Nature Neuroscience 2007 10 11 1387 1394
82. Wainwright M. S., Craft J. M., Griffin W. S. T., Marks A., Pineda J., Padgett K. R., Van Eldik L. J., Increased susceptibility of S100B transgenic mice to peinatal hypoxia-ischemia Annals of Neurology 2004 56 1 61 67
83. Mori T., Koyama N., Arendash G. W., Horikoshi-Sakuraba Y., Tan J., Town T., Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease Glia 2010 58 3 300 314
84. Kim S. H., Smith C. J., Van Eldik L. J., Importance of MAPK pathways for microGlial pro-inflammatory cytokine IL-1 production Neurobiology of Aging 2004 25 4 431 439
85. Reali C., Scintu F., Pillai R., Donato R., Michetti F., Sogos V., S100B counteracts effects of the neurotoxicant trimethyltin on astrocytes and microGlia Journal of Neuroscience Research 2005 81 5 677 686
86. Vincent A. M., Perrone L., Sullivan K. A., Backus C., Sastry A. M., Lastoskie C., Feldman E. L., Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress Endocrinology 2007 148 2 548 558
87. Esposito G., Scuderi C., Lu J., Savani C., De Filippis D., Iuvone T., Steardo L. Jr., Sheen V., Steardo L., S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells Journal of Cellular and Molecular Medicine 2008 12 3 914 927
88. Xu D., Kyriakis J. M., Phosphatidylinositol 3′-Kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products The Journal of Biological Chemistry 2003 278 41 39349 39355
89. Reddy M. A., Li S.-L., Sahar S., Kim Y.-S., Xu Z.-G., Lanting L., Natarajan R., Key role of Src Kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells The Journal of Biological Chemistry 2006 281 19 13685 13693
90. Hudson B. I., Kalea A. Z., Del Mar Arriero M., Harja E., Boulanger E., D'Agati V., Schmidt A. M., Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 The Journal of Biological Chemistry 2008 283 49 34457 34468
91. Griffin W. S. T., Yeralan O., Sheng J. G., Boop F. A., Mrak R. E., Rovnaghi C. R., Burnett B. A., Feoktistova A., Van Eldik L. J., Overexpression of the neurotrophic cytokine S100 in human temporal lobe epilepsy Journal of Neurochemistry 1995 65 1 228 233
92. Sakatani S., Seto-Ohshima A., Shinohara Y., Yamamoto Y., Yamamoto H., Itohara S., Hirase H., Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gmma oscillations in vivo Journal of Neuroscience 2008 28 43 10928 10936
93. Kubista H., Donato R., Hermann A., S100 calcium binding protein affects neuronal electrical discharge activity by modulation of potassium currents Neuroscience 1999 90 2 493 508
94. Wiesmann M., Wandinger K. P., Missler U., Eckhoff D., Rothermundt M., Arolt V., Kirchner H., Elevated plasma levels of S-100b protein in schizophrenic patients Biological Psychiatry 1999 45 11 1508 1511
95. Lara D. R., Gama C. S., Belmonte-de-Abreu P., Portela L. V. C., Gonalves C. A., Fonseca M., Hauck S., Souza D. O., Increased serum S100B protein in schizophrenia: a study in medication-free patients Journal of Psychiatric Research 2001 35 1 11 14
96. Rothermundt M., Missler U., Arolt V., Peters M., Leadbeater J., Wiesmann M., Rudolf S., Wandinger K. P., Kirchner H., Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology Molecular Psychiatry 2001 6 4 445 449
97. Steiner J., Walter M., Wunderlich M. T., Bernstein H.-G., Panteli B., Brauner M., Jacobs R., Gos T., Rothermundt M., Bogerts B., A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE Biological Psychiatry 2009 65 12 1107 1110
98. Rothermundt M., Ohrmann P., Abel S., Siegmund A., Pedersen A., Ponath G., Suslow T., Peters M., Kaestner F., Heindel W., Arolt V., Pfleiderer B., Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 31 2 361 364
99. Steiner J., Bernstein H.-G., Bielau H., Farkas N., Winter J., Dobrowolny H., Brisch R., Gos T., Mawrin C., Myint A. M., Bogerts B., S100B-immunopositive Glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study Journal of Psychiatric Research 2008 42 10 868 876
100. Steiner J., Walter M., Wunderlich M. T., Bernstein H.-G., Panteli B., Brauner M., Jacobs R., Gos T., Rothermundt M., Bogerts B., A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE Biological Psychiatry 2009 65 12 1107 1110
101. Drzyzga., Obuchowicz E., Marcinowska A., Herman Z. S., Cytokines in schizophrenia and the effects of antipsychotic drugs Brain, Behavior, and Immunity 2006 20 6 532 545
102. Potvin S., Stip E., Sepehry A. A., Gendron A., Bah R., Kouassi E., Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review Biological Psychiatry 2008 63 8 801 808
103. Mller N., COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence Current Opinion in Investigational Drugs 2010 11 1 31 42
104. Allore R., O'Hanlon D., Price R., Neilson K., Willard H. F., Cox D. R., Marks A., Dunn R. J., Gene encoding the subunit of S100 protein is on chromosome 21: implications for Down's syndrome Science 1988 239 4845 1311 1313
105. Mrak R. E., Griffin W. S. T., Trisomy 21 and the brain Journal of Neuropathology and Experimental Neurology 2004 63 7 679 685
106. Sheng J. G., Mrak R. E., Rovnaghi C. R., Kozlowska E., Van Eldik L. J., Griffin W. S. T., Human brain S100 and S100 mRNA expression increases with age: pathogenic implications for Alzheimer's disease Neurobiology of Aging 1996 17 3 359 363
107. Steiner J., Walter M., Guest P., Myint A. M., Schiltz K., Panteli B., Brauner M., Bernstein H.-G., Gos T., Herberth M., Schroeter M. L., Schwarz M. J., Westphal S., Bahn S., Bogerts B., Elevated S100B levels in schizophrenia are associated with insulin resistance Molecular Psychiatry 2010 15 1 3 4
108. Steiner J., Schiltz K., Walter M., Wunderlich M. T., Keilhoff G., Brisch R., Bielau H., Bernstein H.-G., Bogerts B., Schroeter M. L., Westphal S., S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research Psychoneuroendocrinology 2010 35 2 321 324
109. Liu J., Shi Y., Tang J., Guo T., Li X., Yang Y., Chen Q., Zhao X., He G., Feng G., Gu N., Zhu S., Liu H., He L., SNPs and haplotypes in the S100B gene reveal association with schizophrenia Biochemical and Biophysical Research Communications 2005 328 1 335 341
110. Roche S., Cassidy F., Zhao C., Badger J., Claffey E., Mooney L., Delaney C., Dobrin S., McKeon P., Candidate gene analysis of 21q22: support for S100B as a susceptibility gene for bipolar affective disorder with psychosis American Journal of Medical Genetics Part B 2007 144 8 1094 1096
111. Hohoff C., Ponath G., Freitag C. M., Kstner F., Krakowitzky P., Domschke K., Koelkebeck K., Kipp F., Von Eiff C., Deckert J., Rothermundt M., Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals American Journal of Medical Genetics Part B 2010 153 1 291 297
112. Poelmans G., Engelen J. J. M., Van Lent-Albrechts J., Smeets H. J., Schoenmakers E., Franke B., Buitelaar J. K., Wuisman-Frerker M., Erens W., Steyaert J., Schrander-Stumpel C., Identification of novel dyslexia candidate genes through the analysis of a chromosomal deletion American Journal of Medical Genetics Part B 2009 150 1 140 147
113. Tsoporis J. N., Izhar S., Leong-Poi H., Desjardins J.-F., Huttunen H. J., Parker T. G., S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction Circulation Research 2010 106 1 93 101
114. Foell D., Wittkowski H., Roth J., Mechanisms of disease: a DAMP view of inflammatory arthritis Nature Clinical Practice Rheumatology 2007 3 7 382 390
115. Su Y. L., Raftery M. J., Goyette J., Hsu K., Geczy C. L., Oxidative modifications of S100 proteins: functional regulation by redox Journal of Leukocyte Biology 2009 86 3 577 587
116. Portela L. V. C., Tort A. B. L., Schaf D. V., Ribeiro L., Nora D. B., Walz R., Rotta L. N., Silva C. T., Busnello J. V., Kapczinski F., Gonalves C. A., Souza D. O., The serum S100B concentration is age dependent Clinical Chemistry 2002 48 6 950 952
117. Ahlemeyer B., Beier H., Semkova I., Schaper C., Krieglstein J., S-100 protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT1A-receptor agonist, Bay x 3702 Brain Research 2000 858 1 121 128
118. Kgel D., Peters M., Knig H.-G., Hashemi S. M. A., Bui N. T., Arolt V., Rothermundt M., Prehn J. H. M., S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury Neuroscience 2004 127 4 913 920
119. Pichiule P., Chavez J. C., Schmidt A. M., Vannucci S. J., Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia The Journal of Biological Chemistry 2007 282 50 36330 36340
120. Winningham-Major F., Staecker J. L., Barger S. W., Coats S., Van Eldik L. J., Neurite extension and neuronal survival activities of recombinant S100 proteins that differ in the content and position of cysteine residues Journal of Cell Biology 1989 109 6 I 3063 3071
121. Haglid K. G., Yang Q., Hamberger A., Bergman S., Widerberg A., Danielsen N., S-100 stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants Brain Research 1997 753 2 196 201
122. Van Eldik L. J., Christie-Pope B., Bolin L. M., Shooter E. M., Whetsell W. O. Jr., Neurotrophic activity of S-100 in cultures of dorsal root ganGlia from embryonic chick and fetal rat Brain Research 1991 542 2 280 285
123. Bhattacharyya A., Oppenheim R. W., Prevette D., Moore B. W., Brackenbury R., Ratner N., S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo Journal of Neurobiology 1992 23 4 451 466
124. Nishi M., Whitaker-Azmitia P. M., Azmitia E. C., Enhanced synaptophysin immunoreactivity in rat hippocampal culture by 5-HT1A agonist, S100b, and corticosteroid receptor agonists Synapse 1996 23 1 1 9
125. Ueda S., Leonardi E. T. K., Bell J. III, Azmitia E. C., Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100 antisense gene Molecular Brain Research 1995 29 2 365 368
126. Selinfreund R. H., Barger S. W., Pledger W. J., Van Eldik L. J., Neurotrophic protein S100 stimulates Glial cell proliferation Proceedings of the National Academy of Sciences of the United States of America 1991 88 9 3554 3558
127. Kleindienst A., McGinn M. J., Harvey H. B., Colello R. J., Hamm R. J., Bullock M. R., Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury Journal of Neurotrauma 2005 22 6 645 655
128. Kleindienst A., Bullock M. R., A critical analysis of the role of the neurotrophic protein S100B in acute brain injury Journal of Neurotrauma 2006 23 8 1185 1200
129. Ellis E. F., Willoughby K. A., Sparks S. A., Chen T., S100B protein is released from rat neonatal neurons, astrocytes, and microGlia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons Journal of Neurochemistry 2007 101 6 1463 1470
130. Willoughby K. A., Kleindienst A., Mller C., Chen T., Muir J. K., Ellis E. F., S100B protein is released by in vitro trauma and reduces delayed neuronal injury Journal of Neurochemistry 2004 91 6 1284 1291
131. Ramos A. J., Rubio M. D., Defagot C., Hischberg L., Villar M. J., Brusco A., The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization Brain Research 2004 1030 2 201 220
132. Tramontina F., Tramontina A. C., Souza D. F., Leite M. C., Gottfried C., Souza D. O., Wofchuk S. T., Gonalves C.-A., Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes Cellular and Molecular Neurobiology 2006 26 1 81 86
133. Schmitt K. R. L., Kern C., Lange P. E., Berger F., Abdul-Khaliq H., Hendrix S., S100B modulates IL-6 release and cytotoxicity from hypothermic brain cells and inhibits hypothermia-induced axonal outgrowth Neuroscience Research 2007 59 1 68 73
134. Manev H., Uz T., Manev R., Glia as a putative target for antidepressant treatments Journal of Affective Disorders 2003 75 1 59 64
135. Charg S. B. P., Rudnicki M. A., Cellular and molecular regulation of muscle regeneration Physiological Reviews 2004 84 1 209 238
136. Rauvala H., Rouhiainen A., Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors Biochimica et Biophysica Acta 2010 1799 1-2 164 170
137. Sorci G., Riuzzi F., Arcuri C., Giambanco I., Donato R., Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding Molecular and Cellular Biology 2004 24 11 4880 4894
138. Riuzzi F., Sorci G., Donato R., The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness: functional inactivation of RAGE in l6 myoblasts results in tumor formation in vivo The Journal of Biological Chemistry 2006 281 12 8242 8253
139. Riuzzi F., Sorci G., Donato R., RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth American Journal of Pathology 2007 171 3 947 961
140. Gerlai R., Roder J., Spatial and nonspatial learning in mice: effects of S100 overexpression and age Neurobiology of Learning and Memory 1996 66 2 143 154
141. Nishiyama H., Knpfel T., Endo S., Itohara S., Glial protein S100B modulates long-term neuronal synaptic plasticity Proceedings of the National Academy of Sciences of the United States of America 2002 99 6 4037 4042
142. Sakatani S., Yamada K., Homma C., Munesue S., Yamamoto Y., Yamamoto H., Hirase H., Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice PloS One 2009 4 12